Accès ouvert
2026
article
OpenAlex
Yi Li, Daosheng Huang, Chang Liu, Zhixiao Zhou et autres
Abstract Adoptive T-cell therapies engineered with T-cell receptors (TCRs) or TCR-like antibodies have shown considerable promise in cancer immunotherapy. However, identifying tumor antigen-specific TCR-like antibodies, particularly against human leukocyte antigen-presented neoantigens, remains challenging. Here, we present a function-based, rather than affinity-based, antibody …
cn, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
E Weigao, Lijiang Fei, Jingjing Wang, Xinru Wang et autres
Cell trans-differentiation offers a powerful means to manipulate cell identities. By exposing cells to a combination of small molecules (SMs), cell trans-differentiation can be induced in a simple and cost-effective manner. However, a comprehensive atlas detailing chemical-induced cell trans-differentiation across multiple cell …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Yu Li, Zhixiao Zhou, Hanyang Yu, Yue Liu et autres
Chimeric antigen receptor (CAR) T cell therapy has achieved great success in treating hematopoietic malignancies; however, post-therapy relapse remains a challenge. Traditionally, multi-specific CAR engineering requires precise arrangement of single-chain variable fragments (scFvs), which can lead to aggregation issues when assembled linearly. …
cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Lihui Wang, Runda Xu, Daosheng Huang, Pai Peng et autres
Identifying epitopes and their corresponding T-cell receptor (TCR) sequences is crucial in the face of rapidly mutating viruses. Peptide synthesis is often required to confirm the exact epitope sequences, which is time-consuming and expensive. In this study, we introduce a scalable workflow …
cn, us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Daosheng Huang, Yi Li, Keyong Sun, Zhixiao Zhou et autres
Targeting tumor-specific neoantigens holds promise for cancer immunotherapy, but their ultra-low expression on tumor cells poses challenges for T cell therapies. Here, we found that chimeric antigen receptors (CARs) exhibit 10–100 times lower sensitivity than T cell receptors (TCRs) when targeting human …
cn
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Yu Zheng, Haihui Jiang, Naixue Yang, Shaoping Shen et autres
cn, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Qingyun Zhou, Zhifei Zhan, Furong Huang, Menghua Zhao et autres
Neonatal meningitis is rare but devastating disease. Multidrug-resistant (MDR, multi-drug resistant) bacteria are a major global health risk. We report an Escherichia coli meningitis isolate with multiple resistance patterns and unusual serotype (O75) that caused sudden neonatal death. The isolate was resistant …
cn
(code pays fourni par la source)
2022
article
OpenAlex
Guangna Liu, Hua Chen, Xingyu Cao, Lemei Jia et autres
Abstract Cytomegalovirus (CMV) infection remains a major cause of mortality after hematopoietic stem cell transplantation (HSCT). Current treatments, including antiviral drugs and adoptive cell therapy with CMV‐specific cytotoxic T lymphocytes (CTLs), only show limited benefits in patients. T‐cell receptor (TCR)‐T cell therapy …
cn
(code pays fourni par la source)
2021
article
OpenAlex
Yue Liu, Guangna Liu, Jiasheng Wang, Zheyu Zheng et autres
Chimeric antigen receptor T (CAR-T) cell therapies have demonstrated high response rate and durable disease control for the treatment of B cell malignancies. However, in the case of solid tumors, CAR-T cells have shown limited efficacy, which is partially attributed to intrinsic …
cn
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Guangna Liu, Hongli Zheng, Daosheng Huang, Fei Yu et autres
Unlike hematological malignancies, solid tumors have proved to be less susceptible to chimeric antigen receptor (CAR)-T cell therapy, which is partially caused by reduced accumulation of therapeutic T cells in tumor site. Since efficient trafficking is the precondition and pivotal step for …
cn
(code pays fourni par la source)
Accès ouvert
2019
peer-review
OpenAlex
Guangna Liu, Hongli Zheng, Daosheng Huang, Fei Yu et autres
Accès ouvert
2018
article
OpenAlex
Xiaoping Han, Renying Wang, Yincong Zhou, Lijiang Fei et autres